Convatec Survey Challenges Assumptions About Leakage in Ostomy Care
6.10.2026 09:00:00 CEST | Business Wire | Press release
New global findings highlight the role of peristomal skin health in improving outcomes and confidence for people living with an ostomy
Convatec, a leading medical products and technologies company focused on solutions for the management of chronic conditions, today released Rethinking leakage in ostomy care, new international research highlighting a significant gap in how peristomal skin health is understood and managed in ostomy care. The findings indicate that skin health plays a critical role in preventing leakage, and supporting confidence in daily life, yet remains widely under-recognised in routine care.
For many people, leakage is not only a clinical or product issue; it can shape whether they feel able to travel, exercise, socialise or take part fully in everyday life. More than half of respondents said they avoid such activities due to worry about their ostomy.
The results of the survey, which included more than 1,800 people living with an ostomy and over 400 healthcare professionals, point to a significant opportunity to improve outcomes through greater focus on peristomal skin health, the specific area of skin that surrounds a stoma, and more consistent, evidence‑based approaches to routine care.
Bruno Pinheiro, President, Ostomy Care, said: “For too long, leakage has been seen as an unavoidable part of life with an ostomy. This research challenges that view. It shows that less visible leakage and skin damage are closely connected, and that by focusing earlier on skin health, we have an opportunity to help people feel more secure, more confident and more in control of their daily lives.”
The research builds on Convatec’s flagship research published in 2025, Perspectives on living with chronic conditions, which revealed that social stigma, rather than the physical condition itself, is the single biggest barrier for 1 in 3 people living with chronic illnesses, with approximately 13.5 million people worldwide living with a stoma1.
Leakage is more common and less visible than many realise
More than half of people living with an ostomy reported experiencing leakage in the past year. However, when asked specifically about under‑baseplate leakage, where waste is not always visible, nearly two thirds said they experienced it within the past month. The difference suggests that people don’t always recognise or describe under-baseplate leakage as a “leak”.
This gap highlights a disconnect between patient experience and how leakage is understood in practice, which means some of the most common issues in ostomy care may be under‑reported and under‑addressed. These “silent leaks” can undermine adhesion and contribute to skin irritation over time.
Skin health is central to breaking the leakage cycle
The findings highlight a recurring cycle in ostomy care: leakage exposes skin to moisture, damaged skin weakens adhesion, and poor adhesion increases the risk of further leakage.
Nearly four in ten respondents reported peristomal skin problems in the past 12 months, most commonly redness, soreness, or itching. While many people attribute these symptoms to adhesive sensitivity, healthcare professionals more often identified moisture exposure and an imperfect seal as key contributors.
This cycle demonstrates that addressing leakage in isolation is not enough. Improving outcomes requires a more holistic approach that prioritises protecting skin health as the foundation for reliable system performance, comfort and confidence.
Confidence is the real-world outcome that matters
Confidence influences how people manage their condition, engage in daily activities and maintain independence. Therefore, it should not be considered a secondary outcome in ostomy care, but one of the clearest measures of whether care is delivering meaningful, real‑world outcomes.
Convatec is committed to helping advance this shift by supporting clearer, more consistent and evidence-based approaches to peristomal skin health. Through initiatives such as Convatec’s me+ personalised support programme, Convatec is helping clinicians and people living with an ostomy better identify, prevent and address avoidable skin complications and ultimately help them feel more secure and confident in everyday life.
The full report, Rethinking leakage in ostomy care, is available at: https://www.convatec.com/ostomy-care/campaigns/ostomy-report/.
References
- Hidden Disabilities Sunflower. Ostomy (2026). Available online at: https://hdsunflower.com/row/insights/post/ostomy (Accessed September 2026).
About the survey
This report is based on a 2026 online survey of 1,841 people living with an ostomy and 431 healthcare professionals across ten countries.
About Convatec
Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. With over 10,000 colleagues, we provide products and services in around 90 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention, treatment for hard to heal wounds, at-risk skin and ulcerated tissue to supporting debilitating conditions, improved patient outcomes and reduced care costs. Convatec’s revenues in 2025 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more please visit http://www.convatecgroup.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20261006739120/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Oulu2026 Boosts Tourism as Björk, Art and Technology Lead the European Capital of Culture Year’s Finale6.10.2026 09:00:00 CEST | Press release
The Oulu2026 European Capital of Culture programme has attracted visitors to northern Finland and contributed to strong tourism growth. According to Visit Oulu statistics, Oulu recorded nearly 475,000 registered overnight stays between January and August 2026, an increase of 12 per cent year on year. International overnight stays rose by 21 per cent to more than 96,600, while domestic overnight stays increased by 9 per cent. The trend continued in August, when international overnight stays grew by almost 29 per cent year on year. Hundreds of events combining art, technology, science, music, theatre and sport continue throughout the final months of 2026. “The programme’s diversity is clearest in the final months. There is something for culture enthusiasts and families alike, with experiences that cannot be found anywhere else. If ever there was a time to visit Oulu, it is now,” says Samu Forsblom, Programme Director of Oulu2026. A major highlight is the Lumo Art & Tech Festival, taking
Ant International and HSBC Expand Real-Time Treasury Management Services to the Middle East6.10.2026 08:30:00 CEST | Press release
Collaboration extends Ant International’s use of tokenised deposits in UAE, supporting faster treasury transactions Ant International today announced an expanded collaboration with HSBC to enhance real-time treasury management services in the Middle East. By leveraging HSBC’s global Tokenised Deposit Service (TDS), Ant International aims to improve the efficiency of its treasury operations across the region. As part of the collaboration, Ant International has successfully completed pilot transactions across two payment corridors connecting the United Arab Emirates and Hong Kong: Intra-UAE dirham transfers: Real-time, dirham-denominated tokenised deposit transactions within the UAE. Cross-border US dollar payments initiated from the UAE: US dollar-denominated tokenised deposit transfers between the UAE and international markets, including Hong Kong and Singapore. These transactions were initiated via WhaleRTP – Ant International’s proprietary, blockchain-based real-time treasury managem
RoslinCT Awarded £7.25 million Scottish Enterprise R&D Grant to Advance Digital Cell Therapy Manufacturing6.10.2026 08:00:00 CEST | Press release
RoslinCT, a leading global cell therapy Contract Development and Manufacturing Organization (CDMO), today announced it has been awarded a Research & Development grant from Scottish Enterprise to accelerate the digital transformation of its manufacturing operations in Scotland. The funding, supported by a Scottish Enterprise R&D grant of up to £7.25 million, forms part of RoslinCT's ambitious digital expansion plan, a multi-year initiative designed to enhance the company's integrated digital and AI capabilities and further strengthen Scotland's position as a global hub for advanced cell and gene therapy manufacturing. The programme will enable the development of a digitally integrated manufacturing environment, improving operational efficiency, data connectivity and manufacturing excellence across RoslinCT's operations. By creating a more connected and data-driven manufacturing environment, RoslinCT will be better positioned to support clients throughout the product lifecycle, helping b
30 Years of Restylane®: Reshaping the Aesthetics Field Through Science-Led, Patient-Centric Innovation6.10.2026 07:00:00 CEST | Press release
Galderma celebrates the 30th anniversary of Restylane, its pioneering range of hyaluronic acid (HA) injectables that established the category as the first to market1 With three decades of innovation across technology, packaging, and treatment areas, Restylane continues to meet growing aesthetic needs, including emerging areas such as medication-driven weight loss, skin quality and menopause1-11 This year’s milestones include the approvals of Restylane Shaype™ in the European Union (EU) for enhancement of the chin region, the new state-of-the-art Restylane syringe in the EU, United States (U.S.), and Canada, and Restylane Volyme™* in the U.S. for temple hollowing, with a dual-layer patent-pending technique leveraging both needle and cannula12-18 With more than 80 clinical trials, 180 publications, around 407,000 patients evaluated for safety, and 77 million treatments administered worldwide, Restylane remains a pioneer in science-backed aesthetic innovation and continues to shape the fu
Posiflex Unveils AI-Powered SCO Series Kiosk to Accelerate the Future of Self-Service Retail6.10.2026 04:33:00 CEST | Press release
A modular, smarter self-checkout platform engineered for weighing, RFID, and loss-prevention automation across diverse retail environments Posiflex Technology, Inc., a global leader in Point of Sale (POS) systems and Online-to-Offline (O2O) solutions, proudly introduces the SCO Series Self-Service Kiosks, an AI-powered platform designed to redefine self-service retail by offering flexible system configurations that support either precise weighing-scale transactions or RFID-enabled automated checkout. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261004628458/en/ Posiflex Unveils AI-Powered SCO Series Kiosk to Accelerate the Future of Self-Service Retail Built to address the evolving needs of both traditional fresh-goods environments and modern RFID-driven retail concepts, the SCO Series enables retailers to elevate operational accuracy, accelerate checkout processes, and future-proof store deployments through modular archit
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom